Table 1.
Demographic and clinical characteristics
| Characteristic | Patients (N=58) |
|---|---|
| Age, years, median (IQR) | 69 (64−74) |
| Female | 39 (67.2) |
| ECOG performance status | |
| 0 | 46 (79.3) |
| 1 | 10 (17.2) |
| 2 | 1 (1.7) |
| Unknown | 1 (1.7) |
| Charlson comorbidity indexa | |
| Median (IQR) | 0 (0−2) |
| Never smoker | 10 (17.2) |
| Pack-years | |
| Median (IQR) | 35.0 (13.5−51.0) |
| FEV1, % | |
| Median (IQR) | 95.5 (82−108) |
| DLCO, % | |
| Median (IQR) | 82 (67−98) |
| CT tumor diameter, cm, median (IQR) | 1.4 (1.2−1.8) |
| Consolidation-to-tumor ratio, median (IQR) | 1.0 (0.6−1.0) |
| SUVmax, median (IQR) | 3.0 (1.7−5.5) |
Unless otherwise note, data are no. (%). CT, computed tomography; DLco, diffusing capacity of the lung for carbon monoxide; ECOG, Eastern Cooperative Oncology Group; FEV1, forced expiratory volume in 1 second; IQR, interquartile range; SD, standard deviation; SUVmax, maximal standardized uptake value.
a
Charlson comorbidity index reported without age assessment.